RetinalGenix Technologies (RTGN) Cash from Financing Activities (2020 - 2026)

RetinalGenix Technologies has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $94619.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $94619.0, down 48.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $476810.0 (down 33.65% YoY), and the FY2025 annual result was $567064.0, down 24.19% from the prior year.
• Cash from Financing Activities came in at $94619.0 for Q1 2026 at RetinalGenix Technologies, down from $142901.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $289981.0 in Q4 2023 to a low of -$41618.0 in Q3 2023.
• The 5-year median for Cash from Financing Activities is $113361.0 (2024), against an average of $120940.4.
• Peak annual rise in Cash from Financing Activities reached 1418.79% in 2023, while the deepest fall reached 166.22% in 2023.
• RetinalGenix Technologies' Cash from Financing Activities stood at $29651.0 in 2022, then jumped by 877.98% to $289981.0 in 2023, then plunged by 60.91% to $113361.0 in 2024, then rose by 26.06% to $142901.0 in 2025, then plunged by 33.79% to $94619.0 in 2026.
• The last three Cash from Financing Activities figures came in at $94619.0 (Q1 2026), $142901.0 (Q4 2025), and $103090.0 (Q3 2025), per Business Quant data.